Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | ABCC8 CL E G H | 6833 | 59 | ORPHA:79134 | DEND syndrome | | | | 245 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | ABCC8 CL E G H | 6833 | 59 | ORPHA:552 | MODY | | | | 245 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | ADA2 CL E G H | 51816 | 1839 | ORPHA:124 | Blackfan-Diamond anemia | | | | 22 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | APPL1 CL E G H | 26060 | 24035 | ORPHA:552 | MODY | | | | 2 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | ATRX CL E G H | 546 | 886 | OMIM:300448 | ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS | | | | 169 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | ATRX CL E G H | 546 | 886 | ORPHA:231401 | Alpha-thalassemia-myelodysplastic syndrome | | | | 169 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | ATRX CL E G H | 546 | 886 | ORPHA:847 | Alpha-thalassemia-X-linked intellectual disability syndrome | HP:0040282 - Frequent | | | 169 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | ATRX CL E G H | 546 | 886 | OMIM:301040 | Alpha-Thalassemia/mental retardation syndrome, X-linked | | | | 169 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | BCL11A CL E G H | 53335 | 13221 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 11 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | BLK CL E G H | 640 | 1057 | ORPHA:552 | MODY | | | | 75 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | | | | 314 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | BSCL2 CL E G H | 26580 | 15832 | OMIM:269700 | Lipodystrophy, congenital generalized, type 2 | | | | 105 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | CEL CL E G H | 1056 | 1848 | ORPHA:552 | MODY | | | | 25 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | CELA2A CL E G H | 63036 | 24609 | OMIM:618620 | ABDOMINAL OBESITY-METABOLIC SYNDROME 4; AOMS4 | | | | 1 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | CYB5A CL E G H | 1528 | 2570 | ORPHA:621 | Hereditary methemoglobinemia | | | | 2 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | CYB5A CL E G H | 1528 | 2570 | OMIM:250790 | Methemoglobinemia and ambiguous genitalia | | | | 2 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | CYB5R3 CL E G H | 1727 | 2873 | ORPHA:621 | Hereditary methemoglobinemia | | | | 24 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | CYB5R3 CL E G H | 1727 | 2873 | OMIM:250800 | Methemoglobinemia due to deficiency of methemoglobin reductase | | | | 24 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | DNAJC21 CL E G H | 134218 | 27030 | OMIM:260400 | Shwachman-Diamond syndrome 1 | | | | 5 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | DNAJC3 CL E G H | 5611 | 9439 | OMIM:616192 | Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus | | | | 3 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | EPOR CL E G H | 2057 | 3416 | ORPHA:90042 | Primary familial polycythemia | HP:0040281 - Very frequent | | | 43 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | GATA1 CL E G H | 2623 | 4170 | ORPHA:231393 | Beta-thalassemia-X-linked thrombocytopenia syndrome | HP:0040281 - Very frequent | | | 29 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | GATA1 CL E G H | 2623 | 4170 | ORPHA:124 | Blackfan-Diamond anemia | | | | 29 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | GCK CL E G H | 2645 | 4195 | OMIM:606176 | DIABETES MELLITUS, PERMANENT NEONATAL; PNDM | | | | 237 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | GCK CL E G H | 2645 | 4195 | ORPHA:552 | MODY | | | | 237 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBA1 CL E G H | 3039 | 4823 | OMIM:604131 | ALPHA-THALASSEMIA | | | | 200 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBA1 CL E G H | 3039 | 4823 | ORPHA:98791 | Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 | | | | 200 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBA1 CL E G H | 3039 | 4823 | ORPHA:163596 | Hb Bart's hydrops fetalis | HP:0040281 - Very frequent | | | 200 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBA1 CL E G H | 3039 | 4823 | OMIM:613978 | Hemoglobin H disease | | | | 200 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBA1 CL E G H | 3039 | 4823 | OMIM:617973 | METHEMOGLOBINEMIA, ALPHA TYPE | | | | 200 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBA2 CL E G H | 3040 | 4824 | OMIM:604131 | ALPHA-THALASSEMIA | | | | 88 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBA2 CL E G H | 3040 | 4824 | ORPHA:98791 | Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 | | | | 88 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBA2 CL E G H | 3040 | 4824 | ORPHA:163596 | Hb Bart's hydrops fetalis | HP:0040281 - Very frequent | | | 88 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBA2 CL E G H | 3040 | 4824 | OMIM:613978 | Hemoglobin H disease | | | | 88 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | OMIM:604131 | ALPHA-THALASSEMIA | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | OMIM:613985 | BETA-THALASSEMIA | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231222 | Beta-thalassemia intermedia | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231214 | Beta-thalassemia major | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | OMIM:603902 | BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231237 | Delta-beta-thalassemia | HP:0040281 - Very frequent | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231226 | Dominant beta-thalassemia | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | OMIM:141749 | Fetal hemoglobin quantitative trait locus 1 | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231242 | Hemoglobin C-beta-thalassemia syndrome | HP:0040281 - Very frequent | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:90039 | Hemoglobin D disease | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:2133 | Hemoglobin E disease | HP:0040281 - Very frequent | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231249 | Hemoglobin E-beta-thalassemia syndrome | HP:0040281 - Very frequent | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:46532 | Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | OMIM:617971 | Methemoglobinemia, Beta type | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:232 | Sickle cell anemia | | | | 580 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBB-LCR CL E G H | 109580095 | | OMIM:613985 | BETA-THALASSEMIA | | | | 1 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBD CL E G H | 3045 | 4829 | ORPHA:231237 | Delta-beta-thalassemia | HP:0040281 - Very frequent | | | 52 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBG1 CL E G H | 3047 | 4831 | ORPHA:231237 | Delta-beta-thalassemia | HP:0040281 - Very frequent | | | 35 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBG1 CL E G H | 3047 | 4831 | OMIM:141749 | Fetal hemoglobin quantitative trait locus 1 | | | | 35 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBG1 CL E G H | 3047 | 4831 | ORPHA:46532 | Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome | | | | 35 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBG1 CL E G H | 3047 | 4831 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 35 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBG2 CL E G H | 3048 | 4832 | OMIM:613977 | Cyanosis, transient neonatal | | | | 50 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBG2 CL E G H | 3048 | 4832 | OMIM:141749 | Fetal hemoglobin quantitative trait locus 1 | | | | 50 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBG2 CL E G H | 3048 | 4832 | ORPHA:46532 | Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome | | | | 50 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HBG2 CL E G H | 3048 | 4832 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 50 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HNF1A CL E G H | 6927 | 11621 | ORPHA:552 | MODY | | | | 161 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | HNF4A CL E G H | 3172 | 5024 | ORPHA:552 | MODY | | | | 138 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | INS CL E G H | 3630 | 6081 | OMIM:618858 | DIABETES MELLITUS, PERMANENT NEONATAL, 4; PNDM4 | | | | 62 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | INS CL E G H | 3630 | 6081 | ORPHA:552 | MODY | | | | 62 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:79134 | DEND syndrome | | | | 127 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | KCNJ11 CL E G H | 3767 | 6257 | OMIM:610582 | Diabetes mellitus, transient neonatal, 3 | | | | 127 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:552 | MODY | | | | 127 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | KLF1 CL E G H | 10661 | 6345 | OMIM:613673 | Anemia, dyserythropoietic congenital, type IV | | | | 42 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | KLF1 CL E G H | 10661 | 6345 | ORPHA:46532 | Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome | | | | 42 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | KLF1 CL E G H | 10661 | 6345 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 42 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | KLF11 CL E G H | 8462 | 11811 | ORPHA:552 | MODY | | | | 78 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | MDM4 CL E G H | 4194 | 6974 | OMIM:618849 | BONE MARROW FAILURE SYNDROME 6; BMFS6 | | | | 1 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | MPL CL E G H | 4352 | 7217 | ORPHA:3319 | Congenital amegakaryocytic thrombocytopenia | HP:0040281 - Very frequent | | | 97 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | MTX2 CL E G H | 10651 | 7506 | OMIM:619127 | MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS | | | | | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | NARS2 CL E G H | 79731 | 26274 | ORPHA:79134 | DEND syndrome | | | | 34 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | NEUROD1 CL E G H | 4760 | 7762 | ORPHA:552 | MODY | | | | 32 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | | | | 2 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | PAX4 CL E G H | 5078 | 8618 | ORPHA:552 | MODY | | | | 55 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | PDX1 CL E G H | 3651 | 6107 | ORPHA:552 | MODY | | | | 30 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPL11 CL E G H | 6135 | 10301 | ORPHA:124 | Blackfan-Diamond anemia | | | | 22 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPL15 CL E G H | 6138 | 10306 | ORPHA:124 | Blackfan-Diamond anemia | | | | 3 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPL18 CL E G H | 6141 | 10310 | ORPHA:124 | Blackfan-Diamond anemia | | | | | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPL26 CL E G H | 6154 | 10327 | ORPHA:124 | Blackfan-Diamond anemia | | | | 3 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPL27 CL E G H | 6155 | 10328 | ORPHA:124 | Blackfan-Diamond anemia | | | | 1 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPL31 CL E G H | 6160 | 10334 | ORPHA:124 | Blackfan-Diamond anemia | | | | | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPL35 CL E G H | 11224 | 10344 | ORPHA:124 | Blackfan-Diamond anemia | | | | | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPL35A CL E G H | 6165 | 10345 | ORPHA:124 | Blackfan-Diamond anemia | | | | 11 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPL5 CL E G H | 6125 | 10360 | ORPHA:124 | Blackfan-Diamond anemia | | | | 40 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPL5 CL E G H | 6125 | 10360 | OMIM:612561 | Diamond-Blackfan anemia 6 | | | | 40 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS10 CL E G H | 6204 | 10383 | ORPHA:124 | Blackfan-Diamond anemia | | | | 26 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS15A CL E G H | 6210 | 10389 | ORPHA:124 | Blackfan-Diamond anemia | | | | | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS17 CL E G H | 6218 | 10397 | ORPHA:124 | Blackfan-Diamond anemia | | | | 5 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS19 CL E G H | 6223 | 10402 | ORPHA:124 | Blackfan-Diamond anemia | | | | 42 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS20 CL E G H | 6224 | 10405 | ORPHA:124 | Blackfan-Diamond anemia | | | | 1 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS24 CL E G H | 6229 | 10411 | ORPHA:124 | Blackfan-Diamond anemia | | | | 22 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS24 CL E G H | 6229 | 10411 | OMIM:610629 | Diamond-Blackfan anemia 3 | | | | 22 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS26 CL E G H | 6231 | 10414 | ORPHA:124 | Blackfan-Diamond anemia | | | | 20 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS27 CL E G H | 6232 | 10416 | ORPHA:124 | Blackfan-Diamond anemia | | | | 1 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS28 CL E G H | 6234 | 10418 | ORPHA:124 | Blackfan-Diamond anemia | | | | 1 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS29 CL E G H | 6235 | 10419 | ORPHA:124 | Blackfan-Diamond anemia | | | | 3 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | RPS7 CL E G H | 6201 | 10440 | ORPHA:124 | Blackfan-Diamond anemia | | | | 20 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | SBDS CL E G H | 51119 | 19440 | OMIM:260400 | Shwachman-Diamond syndrome 1 | | | | 26 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | SRP54 CL E G H | 6729 | 11301 | OMIM:260400 | Shwachman-Diamond syndrome 1 | | | | | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | THPO CL E G H | 7066 | 11795 | ORPHA:3319 | Congenital amegakaryocytic thrombocytopenia | HP:0040281 - Very frequent | | | 23 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | TRMT5 CL E G H | 57570 | 23141 | OMIM:616539 | Combined oxidative phosphorylation deficiency 26 | | | | 4 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | TSR2 CL E G H | 90121 | 25455 | ORPHA:124 | Blackfan-Diamond anemia | | | | 1 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | WRN CL E G H | 7486 | 12791 | OMIM:277700 | Werner syndrome | | | | 310 | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | YIPF5 CL E G H | 81555 | 24877 | OMIM:619278 | MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 2; MEDS2 | | | | | | |
HP:0011902 | HP:0011902 | Abnormal hemoglobin | 0 | ZBTB7A CL E G H | 51341 | 18078 | OMIM:619769 | MACROCEPHALY, NEURODEVELOPMENTAL DELAY, LYMPHOID HYPERPLASIA, AND PERSISTENT FETAL HEMOGLOBIN; MNDLFH | | | | | | |
HP:0011902 | HP:0032146 | HbC hemoglobin | 1 | CL E G H | | | | | | | | | | |
HP:0011902 | HP:0005507 | Hemoglobin Barts | 1 | CL E G H | | | | | | | | | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | ABCC8 CL E G H | 6833 | 59 | ORPHA:79134 | DEND syndrome | HP:0040281 - Very frequent | | | 245 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | ABCC8 CL E G H | 6833 | 59 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 245 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | ADA2 CL E G H | 51816 | 1839 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 22 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | APPL1 CL E G H | 26060 | 24035 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 2 | | |
HP:0011902 | HP:0005560 | Imbalanced hemoglobin synthesis | 1 | ATRX CL E G H | 546 | 886 | OMIM:300448 | ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS | | | | 169 | | |
HP:0011902 | HP:0011903 | HbH hemoglobin | 1 | ATRX CL E G H | 546 | 886 | OMIM:300448 | ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS | | | | 169 | | |
HP:0011902 | HP:0011903 | HbH hemoglobin | 1 | ATRX CL E G H | 546 | 886 | ORPHA:231401 | Alpha-thalassemia-myelodysplastic syndrome | HP:0040281 - Very frequent | | | 169 | | |
HP:0011902 | HP:0011903 | HbH hemoglobin | 1 | ATRX CL E G H | 546 | 886 | OMIM:301040 | Alpha-Thalassemia/mental retardation syndrome, X-linked | . | | | 169 | | |
HP:0011902 | HP:0005560 | Imbalanced hemoglobin synthesis | 1 | ATRX CL E G H | 546 | 886 | OMIM:301040 | Alpha-Thalassemia/mental retardation syndrome, X-linked | | | | 169 | | |
HP:0011902 | HP:0045047 | HbS hemoglobin | 1 | BCL11A CL E G H | 53335 | 13221 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 11 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | BCL11A CL E G H | 53335 | 13221 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 11 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | BLK CL E G H | 640 | 1057 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 75 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | | | | 314 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | BSCL2 CL E G H | 26580 | 15832 | OMIM:269700 | Lipodystrophy, congenital generalized, type 2 | | | | 105 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | CEL CL E G H | 1056 | 1848 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 25 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | CELA2A CL E G H | 63036 | 24609 | OMIM:618620 | ABDOMINAL OBESITY-METABOLIC SYNDROME 4; AOMS4 | | | | 1 | | |
HP:0011902 | HP:0012119 | Methemoglobinemia | 1 | CYB5A CL E G H | 1528 | 2570 | ORPHA:621 | Hereditary methemoglobinemia | HP:0040281 - Very frequent | | | 2 | | |
HP:0011902 | HP:0012119 | Methemoglobinemia | 1 | CYB5A CL E G H | 1528 | 2570 | OMIM:250790 | Methemoglobinemia and ambiguous genitalia | . | | | 2 | | |
HP:0011902 | HP:0012119 | Methemoglobinemia | 1 | CYB5R3 CL E G H | 1727 | 2873 | ORPHA:621 | Hereditary methemoglobinemia | HP:0040281 - Very frequent | | | 24 | | |
HP:0011902 | HP:0012119 | Methemoglobinemia | 1 | CYB5R3 CL E G H | 1727 | 2873 | OMIM:250800 | Methemoglobinemia due to deficiency of methemoglobin reductase | . | | | 24 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | DNAJC21 CL E G H | 134218 | 27030 | OMIM:260400 | Shwachman-Diamond syndrome 1 | . | | | 5 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | DNAJC3 CL E G H | 5611 | 9439 | OMIM:616192 | Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus | | | | 3 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | GATA1 CL E G H | 2623 | 4170 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 29 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | GCK CL E G H | 2645 | 4195 | OMIM:606176 | DIABETES MELLITUS, PERMANENT NEONATAL; PNDM | | | | 237 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | GCK CL E G H | 2645 | 4195 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 237 | | |
HP:0011902 | HP:0005560 | Imbalanced hemoglobin synthesis | 1 | HBA1 CL E G H | 3039 | 4823 | OMIM:604131 | ALPHA-THALASSEMIA | | | | 200 | | |
HP:0011902 | HP:0011903 | HbH hemoglobin | 1 | HBA1 CL E G H | 3039 | 4823 | ORPHA:98791 | Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 | HP:0040281 - Very frequent | | | 200 | | |
HP:0011902 | HP:0011903 | HbH hemoglobin | 1 | HBA1 CL E G H | 3039 | 4823 | OMIM:613978 | Hemoglobin H disease | . | | | 200 | | |
HP:0011902 | HP:0005560 | Imbalanced hemoglobin synthesis | 1 | HBA1 CL E G H | 3039 | 4823 | OMIM:613978 | Hemoglobin H disease | | | | 200 | | |
HP:0011902 | HP:0012119 | Methemoglobinemia | 1 | HBA1 CL E G H | 3039 | 4823 | OMIM:617973 | METHEMOGLOBINEMIA, ALPHA TYPE | | | | 200 | | |
HP:0011902 | HP:0005560 | Imbalanced hemoglobin synthesis | 1 | HBA2 CL E G H | 3040 | 4824 | OMIM:604131 | ALPHA-THALASSEMIA | | | | 88 | | |
HP:0011902 | HP:0011903 | HbH hemoglobin | 1 | HBA2 CL E G H | 3040 | 4824 | ORPHA:98791 | Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 | HP:0040281 - Very frequent | | | 88 | | |
HP:0011902 | HP:0005560 | Imbalanced hemoglobin synthesis | 1 | HBA2 CL E G H | 3040 | 4824 | OMIM:613978 | Hemoglobin H disease | | | | 88 | | |
HP:0011902 | HP:0011903 | HbH hemoglobin | 1 | HBA2 CL E G H | 3040 | 4824 | OMIM:613978 | Hemoglobin H disease | . | | | 88 | | |
HP:0011902 | HP:0005560 | Imbalanced hemoglobin synthesis | 1 | HBB CL E G H | 3043 | 4827 | OMIM:604131 | ALPHA-THALASSEMIA | | | | 580 | | |
HP:0011902 | HP:0005560 | Imbalanced hemoglobin synthesis | 1 | HBB CL E G H | 3043 | 4827 | OMIM:613985 | BETA-THALASSEMIA | | | | 580 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:231222 | Beta-thalassemia intermedia | HP:0040281 - Very frequent | | | 580 | | |
HP:0011902 | HP:0045048 | Increased HbA2 hemoglobin | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:231222 | Beta-thalassemia intermedia | HP:0040282 - Frequent | | | 580 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:231214 | Beta-thalassemia major | HP:0040281 - Very frequent | | | 580 | | |
HP:0011902 | HP:0011905 | Reduced hemoglobin A | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:231214 | Beta-thalassemia major | HP:0040281 - Very frequent | | | 580 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBB CL E G H | 3043 | 4827 | OMIM:603902 | BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE | | | | 580 | | |
HP:0011902 | HP:0045048 | Increased HbA2 hemoglobin | 1 | HBB CL E G H | 3043 | 4827 | OMIM:603902 | BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE | | | | 580 | | |
HP:0011902 | HP:0011905 | Reduced hemoglobin A | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:231226 | Dominant beta-thalassemia | HP:0040281 - Very frequent | | | 580 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:231226 | Dominant beta-thalassemia | HP:0040281 - Very frequent | | | 580 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBB CL E G H | 3043 | 4827 | OMIM:141749 | Fetal hemoglobin quantitative trait locus 1 | . | | | 580 | | |
HP:0011902 | HP:0045047 | HbS hemoglobin | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:90039 | Hemoglobin D disease | | | | 580 | | |
HP:0011902 | HP:0005560 | Imbalanced hemoglobin synthesis | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:90039 | Hemoglobin D disease | | | | 580 | | |
HP:0011902 | HP:0045048 | Increased HbA2 hemoglobin | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:90039 | Hemoglobin D disease | | | | 580 | | |
HP:0011902 | HP:0011905 | Reduced hemoglobin A | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:90039 | Hemoglobin D disease | | | | 580 | | |
HP:0011902 | HP:0011905 | Reduced hemoglobin A | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:2133 | Hemoglobin E disease | HP:0040282 - Frequent | | | 580 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:46532 | Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome | HP:0040281 - Very frequent | | | 580 | | |
HP:0011902 | HP:0045047 | HbS hemoglobin | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 580 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 580 | | |
HP:0011902 | HP:0012119 | Methemoglobinemia | 1 | HBB CL E G H | 3043 | 4827 | OMIM:617971 | Methemoglobinemia, Beta type | . | | | 580 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:232 | Sickle cell anemia | HP:0040283 - Occasional | | | 580 | | |
HP:0011902 | HP:0005560 | Imbalanced hemoglobin synthesis | 1 | HBB-LCR CL E G H | 109580095 | | OMIM:613985 | BETA-THALASSEMIA | | | | 1 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBG1 CL E G H | 3047 | 4831 | OMIM:141749 | Fetal hemoglobin quantitative trait locus 1 | . | | | 35 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBG1 CL E G H | 3047 | 4831 | ORPHA:46532 | Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome | HP:0040281 - Very frequent | | | 35 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBG1 CL E G H | 3047 | 4831 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 35 | | |
HP:0011902 | HP:0045047 | HbS hemoglobin | 1 | HBG1 CL E G H | 3047 | 4831 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 35 | | |
HP:0011902 | HP:0012119 | Methemoglobinemia | 1 | HBG2 CL E G H | 3048 | 4832 | OMIM:613977 | Cyanosis, transient neonatal | . | | | 50 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBG2 CL E G H | 3048 | 4832 | OMIM:141749 | Fetal hemoglobin quantitative trait locus 1 | . | | | 50 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBG2 CL E G H | 3048 | 4832 | ORPHA:46532 | Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome | HP:0040281 - Very frequent | | | 50 | | |
HP:0011902 | HP:0045047 | HbS hemoglobin | 1 | HBG2 CL E G H | 3048 | 4832 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 50 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | HBG2 CL E G H | 3048 | 4832 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 50 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | HNF1A CL E G H | 6927 | 11621 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 161 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | HNF4A CL E G H | 3172 | 5024 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 138 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | INS CL E G H | 3630 | 6081 | OMIM:618858 | DIABETES MELLITUS, PERMANENT NEONATAL, 4; PNDM4 | | | | 62 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | INS CL E G H | 3630 | 6081 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 62 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:79134 | DEND syndrome | HP:0040281 - Very frequent | | | 127 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | KCNJ11 CL E G H | 3767 | 6257 | OMIM:610582 | Diabetes mellitus, transient neonatal, 3 | . | | | 127 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 127 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | KLF1 CL E G H | 10661 | 6345 | OMIM:613673 | Anemia, dyserythropoietic congenital, type IV | | | | 42 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | KLF1 CL E G H | 10661 | 6345 | ORPHA:46532 | Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome | HP:0040281 - Very frequent | | | 42 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | KLF1 CL E G H | 10661 | 6345 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 42 | | |
HP:0011902 | HP:0045047 | HbS hemoglobin | 1 | KLF1 CL E G H | 10661 | 6345 | ORPHA:251380 | Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | | | | 42 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | KLF11 CL E G H | 8462 | 11811 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 78 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | MDM4 CL E G H | 4194 | 6974 | OMIM:618849 | BONE MARROW FAILURE SYNDROME 6; BMFS6 | | | | 1 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | MTX2 CL E G H | 10651 | 7506 | OMIM:619127 | MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS | | | | | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | NARS2 CL E G H | 79731 | 26274 | ORPHA:79134 | DEND syndrome | HP:0040281 - Very frequent | | | 34 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | NEUROD1 CL E G H | 4760 | 7762 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 32 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | . | | | 2 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | PAX4 CL E G H | 5078 | 8618 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 55 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | PDX1 CL E G H | 3651 | 6107 | ORPHA:552 | MODY | HP:0040282 - Frequent | | | 30 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPL11 CL E G H | 6135 | 10301 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 22 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPL15 CL E G H | 6138 | 10306 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 3 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPL18 CL E G H | 6141 | 10310 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPL26 CL E G H | 6154 | 10327 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 3 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPL27 CL E G H | 6155 | 10328 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 1 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPL31 CL E G H | 6160 | 10334 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPL35 CL E G H | 11224 | 10344 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPL35A CL E G H | 6165 | 10345 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 11 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPL5 CL E G H | 6125 | 10360 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 40 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPL5 CL E G H | 6125 | 10360 | OMIM:612561 | Diamond-Blackfan anemia 6 | | | | 40 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS10 CL E G H | 6204 | 10383 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 26 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS15A CL E G H | 6210 | 10389 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS17 CL E G H | 6218 | 10397 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 5 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS19 CL E G H | 6223 | 10402 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 42 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS20 CL E G H | 6224 | 10405 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 1 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS24 CL E G H | 6229 | 10411 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 22 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS24 CL E G H | 6229 | 10411 | OMIM:610629 | Diamond-Blackfan anemia 3 | | | | 22 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS26 CL E G H | 6231 | 10414 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 20 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS27 CL E G H | 6232 | 10416 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 1 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS28 CL E G H | 6234 | 10418 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 1 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS29 CL E G H | 6235 | 10419 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 3 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | RPS7 CL E G H | 6201 | 10440 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 20 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | SBDS CL E G H | 51119 | 19440 | OMIM:260400 | Shwachman-Diamond syndrome 1 | . | | | 26 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | SRP54 CL E G H | 6729 | 11301 | OMIM:260400 | Shwachman-Diamond syndrome 1 | . | | | | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | TRMT5 CL E G H | 57570 | 23141 | OMIM:616539 | Combined oxidative phosphorylation deficiency 26 | | | | 4 | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | TSR2 CL E G H | 90121 | 25455 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 1 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | WRN CL E G H | 7486 | 12791 | OMIM:277700 | Werner syndrome | | | | 310 | | |
HP:0011902 | HP:0040217 | Elevated hemoglobin A1c | 1 | YIPF5 CL E G H | 81555 | 24877 | OMIM:619278 | MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 2; MEDS2 | | | | | | |
HP:0011902 | HP:0011904 | Persistence of hemoglobin F | 1 | ZBTB7A CL E G H | 51341 | 18078 | OMIM:619769 | MACROCEPHALY, NEURODEVELOPMENTAL DELAY, LYMPHOID HYPERPLASIA, AND PERSISTENT FETAL HEMOGLOBIN; MNDLFH | | | | | | |
HP:0011902 | HP:0011907 | Reduced alpha/beta synthesis ratio | 2 | ATRX CL E G H | 546 | 886 | OMIM:300448 | ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS | | | | 169 | | |
HP:0011902 | HP:0011907 | Reduced alpha/beta synthesis ratio | 2 | ATRX CL E G H | 546 | 886 | OMIM:301040 | Alpha-Thalassemia/mental retardation syndrome, X-linked | . | | | 169 | | |
HP:0011902 | HP:0011907 | Reduced alpha/beta synthesis ratio | 2 | HBA1 CL E G H | 3039 | 4823 | OMIM:604131 | ALPHA-THALASSEMIA | . | | | 200 | | |
HP:0011902 | HP:0011907 | Reduced alpha/beta synthesis ratio | 2 | HBA1 CL E G H | 3039 | 4823 | OMIM:613978 | Hemoglobin H disease | . | | | 200 | | |
HP:0011902 | HP:0011907 | Reduced alpha/beta synthesis ratio | 2 | HBA2 CL E G H | 3040 | 4824 | OMIM:604131 | ALPHA-THALASSEMIA | . | | | 88 | | |
HP:0011902 | HP:0011907 | Reduced alpha/beta synthesis ratio | 2 | HBA2 CL E G H | 3040 | 4824 | OMIM:613978 | Hemoglobin H disease | . | | | 88 | | |
HP:0011902 | HP:0011907 | Reduced alpha/beta synthesis ratio | 2 | HBB CL E G H | 3043 | 4827 | OMIM:604131 | ALPHA-THALASSEMIA | . | | | 580 | | |
HP:0011902 | HP:0011906 | Reduced beta/alpha synthesis ratio | 2 | HBB CL E G H | 3043 | 4827 | OMIM:613985 | BETA-THALASSEMIA | . | | | 580 | | |
HP:0011902 | HP:0011907 | Reduced alpha/beta synthesis ratio | 2 | HBB CL E G H | 3043 | 4827 | ORPHA:90039 | Hemoglobin D disease | | | | 580 | | |
HP:0011902 | HP:0011906 | Reduced beta/alpha synthesis ratio | 2 | HBB CL E G H | 3043 | 4827 | ORPHA:90039 | Hemoglobin D disease | | | | 580 | | |
HP:0011902 | HP:0011906 | Reduced beta/alpha synthesis ratio | 2 | HBB-LCR CL E G H | 109580095 | | OMIM:613985 | BETA-THALASSEMIA | . | | | 1 | | |